- Home
- TDS vs ALKS Comparison
TDS vs ALKS Comparison
Compare TDS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDS
- ALKS
- Stock Information
- Founded
- TDS 1968
- ALKS 1987
- Country
- TDS United States
- ALKS Ireland
- Employees
- TDS N/A
- ALKS N/A
- Industry
- TDS Telecommunications Equipment
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- TDS Telecommunications
- ALKS Health Care
- Exchange
- TDS Nasdaq
- ALKS Nasdaq
- Market Cap
- TDS 4.4B
- ALKS 4.9B
- IPO Year
- TDS N/A
- ALKS 1991
- Fundamental
- Price
- TDS $39.34
- ALKS $31.51
- Analyst Decision
- TDS Buy
- ALKS Strong Buy
- Analyst Count
- TDS 2
- ALKS 14
- Target Price
- TDS $52.00
- ALKS $41.43
- AVG Volume (30 Days)
- TDS 1.1M
- ALKS 1.8M
- Earning Date
- TDS 10-31-2025
- ALKS 10-23-2025
- Dividend Yield
- TDS 0.41%
- ALKS N/A
- EPS Growth
- TDS N/A
- ALKS 21.99
- EPS
- TDS N/A
- ALKS 2.08
- Revenue
- TDS $4,805,000,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- TDS N/A
- ALKS N/A
- Revenue Next Year
- TDS $0.29
- ALKS $1.59
- P/E Ratio
- TDS N/A
- ALKS $15.16
- Revenue Growth
- TDS N/A
- ALKS N/A
- 52 Week Low
- TDS $22.51
- ALKS $25.17
- 52 Week High
- TDS $42.74
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- TDS 49.76
- ALKS 63.86
- Support Level
- TDS $38.59
- ALKS $30.70
- Resistance Level
- TDS $39.88
- ALKS $31.68
- Average True Range (ATR)
- TDS 0.84
- ALKS 0.77
- MACD
- TDS 0.10
- ALKS 0.32
- Stochastic Oscillator
- TDS 59.71
- ALKS 86.41
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.